nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—HSPA4—liver cancer	0.00488	0.108	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—TAT—liver cancer	0.00244	0.0538	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GJB1—liver cancer	0.00215	0.0474	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GLUL—liver cancer	0.00166	0.0366	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—GLUL—liver cancer	0.00144	0.0318	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SIX3—liver cancer	0.00131	0.0289	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TERT—liver cancer	0.00116	0.0257	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—GLUL—liver cancer	0.0011	0.0244	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GLUL—liver cancer	0.000955	0.0211	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—PSMA4—liver cancer	0.000951	0.021	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—PSMD10—liver cancer	0.000951	0.021	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GOT2—liver cancer	0.000925	0.0204	CbGpPWpGaD
Gabapentin—Muscular weakness—Epirubicin—liver cancer	0.000876	0.000917	CcSEcCtD
Gabapentin—Cardiac arrest—Doxorubicin—liver cancer	0.000874	0.000915	CcSEcCtD
Gabapentin—Dizziness—Sorafenib—liver cancer	0.000873	0.000915	CcSEcCtD
Gabapentin—Mood swings—Doxorubicin—liver cancer	0.000871	0.000912	CcSEcCtD
Gabapentin—Ataxia—Doxorubicin—liver cancer	0.000864	0.000905	CcSEcCtD
Gabapentin—Blood creatinine increased—Doxorubicin—liver cancer	0.000861	0.000902	CcSEcCtD
Gabapentin—Influenza—Epirubicin—liver cancer	0.000858	0.000899	CcSEcCtD
Gabapentin—Asthma—Epirubicin—liver cancer	0.000858	0.000899	CcSEcCtD
Gabapentin—Dysphagia—Epirubicin—liver cancer	0.000858	0.000899	CcSEcCtD
Gabapentin—Dehydration—Doxorubicin—liver cancer	0.000855	0.000895	CcSEcCtD
Gabapentin—Eosinophilia—Epirubicin—liver cancer	0.00085	0.00089	CcSEcCtD
Gabapentin—Liver function test abnormal—Doxorubicin—liver cancer	0.000848	0.000889	CcSEcCtD
Gabapentin—Dry skin—Doxorubicin—liver cancer	0.000842	0.000882	CcSEcCtD
Gabapentin—Pancreatitis—Epirubicin—liver cancer	0.000842	0.000881	CcSEcCtD
Gabapentin—Vomiting—Sorafenib—liver cancer	0.00084	0.00088	CcSEcCtD
Gabapentin—Angina pectoris—Epirubicin—liver cancer	0.000836	0.000876	CcSEcCtD
Gabapentin—Rash—Sorafenib—liver cancer	0.000833	0.000872	CcSEcCtD
Gabapentin—Dermatitis—Sorafenib—liver cancer	0.000832	0.000871	CcSEcCtD
Gabapentin—Breast disorder—Doxorubicin—liver cancer	0.00083	0.00087	CcSEcCtD
Gabapentin—Headache—Sorafenib—liver cancer	0.000827	0.000867	CcSEcCtD
Gabapentin—Bronchitis—Epirubicin—liver cancer	0.000826	0.000865	CcSEcCtD
Gabapentin—Nasopharyngitis—Doxorubicin—liver cancer	0.000822	0.000861	CcSEcCtD
Gabapentin—Gastritis—Doxorubicin—liver cancer	0.000813	0.000852	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKCE—liver cancer	0.000812	0.0179	CbGpPWpGaD
Gabapentin—Muscular weakness—Doxorubicin—liver cancer	0.00081	0.000849	CcSEcCtD
Gabapentin—Dysuria—Epirubicin—liver cancer	0.000803	0.000841	CcSEcCtD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GOT1—liver cancer	0.000799	0.0176	CbGpPWpGaD
Gabapentin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000798	0.000836	CcSEcCtD
Gabapentin—Dysphagia—Doxorubicin—liver cancer	0.000794	0.000832	CcSEcCtD
Gabapentin—Asthma—Doxorubicin—liver cancer	0.000794	0.000832	CcSEcCtD
Gabapentin—Influenza—Doxorubicin—liver cancer	0.000794	0.000832	CcSEcCtD
Gabapentin—Pollakiuria—Epirubicin—liver cancer	0.000793	0.000831	CcSEcCtD
Gabapentin—Eosinophilia—Doxorubicin—liver cancer	0.000786	0.000824	CcSEcCtD
Gabapentin—Nausea—Sorafenib—liver cancer	0.000785	0.000822	CcSEcCtD
Gabapentin—Photosensitivity reaction—Epirubicin—liver cancer	0.000783	0.000821	CcSEcCtD
Gabapentin—Weight increased—Epirubicin—liver cancer	0.000781	0.000818	CcSEcCtD
Gabapentin—Pancreatitis—Doxorubicin—liver cancer	0.000779	0.000816	CcSEcCtD
Gabapentin—Weight decreased—Epirubicin—liver cancer	0.000777	0.000813	CcSEcCtD
Gabapentin—Hyperglycaemia—Epirubicin—liver cancer	0.000774	0.000811	CcSEcCtD
Gabapentin—Angina pectoris—Doxorubicin—liver cancer	0.000774	0.00081	CcSEcCtD
Gabapentin—Pneumonia—Epirubicin—liver cancer	0.00077	0.000806	CcSEcCtD
Gabapentin—Infestation—Epirubicin—liver cancer	0.000765	0.000802	CcSEcCtD
Gabapentin—Infestation NOS—Epirubicin—liver cancer	0.000765	0.000802	CcSEcCtD
Gabapentin—Drowsiness—Epirubicin—liver cancer	0.000765	0.000802	CcSEcCtD
Gabapentin—Bronchitis—Doxorubicin—liver cancer	0.000764	0.0008	CcSEcCtD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—liver cancer	0.000762	0.0168	CbGpPWpGaD
Gabapentin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000759	0.000795	CcSEcCtD
Gabapentin—Renal failure—Epirubicin—liver cancer	0.000752	0.000788	CcSEcCtD
Gabapentin—Neuropathy peripheral—Epirubicin—liver cancer	0.00075	0.000786	CcSEcCtD
Gabapentin—Stomatitis—Epirubicin—liver cancer	0.000746	0.000781	CcSEcCtD
Gabapentin—Jaundice—Epirubicin—liver cancer	0.000746	0.000781	CcSEcCtD
Gabapentin—Urinary tract infection—Epirubicin—liver cancer	0.000744	0.000779	CcSEcCtD
Gabapentin—Conjunctivitis—Epirubicin—liver cancer	0.000744	0.000779	CcSEcCtD
Gabapentin—Dysuria—Doxorubicin—liver cancer	0.000743	0.000778	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000738	0.000773	CcSEcCtD
Gabapentin—Sweating—Epirubicin—liver cancer	0.000734	0.000769	CcSEcCtD
Gabapentin—Pollakiuria—Doxorubicin—liver cancer	0.000734	0.000768	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—GLUL—liver cancer	0.000732	0.0162	CbGpPWpGaD
Gabapentin—Haematuria—Epirubicin—liver cancer	0.00073	0.000764	CcSEcCtD
Gabapentin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000725	0.000759	CcSEcCtD
Gabapentin—Hepatobiliary disease—Epirubicin—liver cancer	0.000724	0.000758	CcSEcCtD
Gabapentin—Weight increased—Doxorubicin—liver cancer	0.000723	0.000757	CcSEcCtD
Gabapentin—Epistaxis—Epirubicin—liver cancer	0.000722	0.000756	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—liver cancer	0.000719	0.000753	CcSEcCtD
Gabapentin—Sinusitis—Epirubicin—liver cancer	0.000718	0.000752	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—liver cancer	0.000716	0.00075	CcSEcCtD
Gabapentin—Pneumonia—Doxorubicin—liver cancer	0.000712	0.000746	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—liver cancer	0.000708	0.000742	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—liver cancer	0.000708	0.000742	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—liver cancer	0.000708	0.000742	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000702	0.000735	CcSEcCtD
Gabapentin—Bradycardia—Epirubicin—liver cancer	0.000699	0.000733	CcSEcCtD
Gabapentin—Renal failure—Doxorubicin—liver cancer	0.000696	0.000729	CcSEcCtD
Gabapentin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000694	0.000727	CcSEcCtD
Gabapentin—Stomatitis—Doxorubicin—liver cancer	0.00069	0.000723	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—liver cancer	0.00069	0.000723	CcSEcCtD
Gabapentin—Rhinitis—Epirubicin—liver cancer	0.000689	0.000721	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—liver cancer	0.000688	0.000721	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—liver cancer	0.000688	0.000721	CcSEcCtD
Gabapentin—Hepatitis—Epirubicin—liver cancer	0.000687	0.00072	CcSEcCtD
Gabapentin—Haemorrhage—Epirubicin—liver cancer	0.000687	0.00072	CcSEcCtD
Gabapentin—Hypoaesthesia—Epirubicin—liver cancer	0.000684	0.000716	CcSEcCtD
Gabapentin—Pharyngitis—Epirubicin—liver cancer	0.000682	0.000714	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—liver cancer	0.000679	0.000711	CcSEcCtD
Gabapentin—Urinary tract disorder—Epirubicin—liver cancer	0.000679	0.000711	CcSEcCtD
Gabapentin—Oedema peripheral—Epirubicin—liver cancer	0.000677	0.000709	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—liver cancer	0.000675	0.000707	CcSEcCtD
Gabapentin—Connective tissue disorder—Epirubicin—liver cancer	0.000675	0.000707	CcSEcCtD
Gabapentin—Urethral disorder—Epirubicin—liver cancer	0.000673	0.000705	CcSEcCtD
Gabapentin—Hepatobiliary disease—Doxorubicin—liver cancer	0.00067	0.000702	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—liver cancer	0.000668	0.0007	CcSEcCtD
Gabapentin—Sinusitis—Doxorubicin—liver cancer	0.000664	0.000696	CcSEcCtD
Gabapentin—Visual impairment—Epirubicin—liver cancer	0.000662	0.000694	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—liver cancer	0.000653	0.0144	CbGpPWpGaD
Gabapentin—Erythema multiforme—Epirubicin—liver cancer	0.00065	0.00068	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—liver cancer	0.000647	0.000678	CcSEcCtD
Gabapentin—Eye disorder—Epirubicin—liver cancer	0.000642	0.000673	CcSEcCtD
Gabapentin—Tinnitus—Epirubicin—liver cancer	0.000641	0.000671	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—liver cancer	0.000638	0.000668	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—liver cancer	0.000637	0.000668	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—liver cancer	0.000636	0.000666	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—liver cancer	0.000636	0.000666	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—liver cancer	0.000633	0.000663	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—liver cancer	0.000631	0.000661	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—liver cancer	0.000628	0.000658	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—liver cancer	0.000626	0.000656	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—liver cancer	0.000625	0.000654	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—liver cancer	0.000623	0.000653	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—liver cancer	0.000621	0.00065	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—liver cancer	0.000619	0.000649	CcSEcCtD
Gabapentin—Chills—Epirubicin—liver cancer	0.000616	0.000646	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—liver cancer	0.000613	0.000642	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—liver cancer	0.000607	0.000636	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—liver cancer	0.000602	0.00063	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—liver cancer	0.000601	0.00063	CcSEcCtD
Gabapentin—Erythema—Epirubicin—liver cancer	0.000598	0.000626	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—liver cancer	0.000598	0.000626	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—liver cancer	0.000594	0.000622	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—liver cancer	0.000593	0.000621	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—liver cancer	0.00059	0.000618	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—liver cancer	0.000589	0.000617	CcSEcCtD
Gabapentin—Tension—Epirubicin—liver cancer	0.000587	0.000615	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—liver cancer	0.000586	0.000613	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—liver cancer	0.000581	0.000608	CcSEcCtD
Gabapentin—Back pain—Epirubicin—liver cancer	0.000579	0.000606	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—liver cancer	0.000575	0.000602	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—liver cancer	0.000574	0.000601	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—liver cancer	0.000573	0.0006	CcSEcCtD
Gabapentin—Chills—Doxorubicin—liver cancer	0.00057	0.000597	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—liver cancer	0.000564	0.00059	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—liver cancer	0.000562	0.000588	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—liver cancer	0.000557	0.000583	CcSEcCtD
Gabapentin—Ill-defined disorder—Epirubicin—liver cancer	0.000555	0.000581	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—liver cancer	0.000553	0.00058	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—liver cancer	0.000553	0.00058	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—liver cancer	0.000553	0.000579	CcSEcCtD
Gabapentin—Agitation—Epirubicin—liver cancer	0.00055	0.000576	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—liver cancer	0.000545	0.000571	CcSEcCtD
Gabapentin—Tension—Doxorubicin—liver cancer	0.000543	0.000569	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—liver cancer	0.000542	0.000568	CcSEcCtD
Gabapentin—Malaise—Epirubicin—liver cancer	0.000539	0.000565	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—liver cancer	0.000539	0.0119	CbGpPWpGaD
Gabapentin—Nervousness—Doxorubicin—liver cancer	0.000537	0.000563	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—liver cancer	0.000537	0.000563	CcSEcCtD
Gabapentin—Syncope—Epirubicin—liver cancer	0.000536	0.000562	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—liver cancer	0.000535	0.000561	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—liver cancer	0.000535	0.000561	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—liver cancer	0.000532	0.000557	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—liver cancer	0.000529	0.000554	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—liver cancer	0.000526	0.000551	CcSEcCtD
Gabapentin—Cough—Epirubicin—liver cancer	0.000522	0.000547	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—liver cancer	0.000522	0.000546	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—liver cancer	0.000518	0.000543	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—liver cancer	0.000516	0.000541	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—liver cancer	0.000513	0.000538	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—liver cancer	0.000511	0.000536	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—liver cancer	0.000509	0.000533	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—liver cancer	0.000509	0.000533	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—liver cancer	0.000509	0.000533	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—liver cancer	0.000509	0.000533	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—liver cancer	0.000507	0.000531	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000506	0.00053	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—liver cancer	0.000503	0.000527	CcSEcCtD
Gabapentin—BCAT1—Metabolism—UGDH—liver cancer	0.000502	0.0111	CbGpPWpGaD
Gabapentin—Malaise—Doxorubicin—liver cancer	0.000499	0.000523	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—liver cancer	0.000498	0.000522	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—AHR—liver cancer	0.000498	0.011	CbGpPWpGaD
Gabapentin—Vertigo—Doxorubicin—liver cancer	0.000497	0.000521	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—liver cancer	0.000496	0.00052	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—liver cancer	0.000495	0.000519	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—liver cancer	0.000492	0.000516	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—liver cancer	0.000489	0.000512	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—liver cancer	0.000488	0.000511	CcSEcCtD
Gabapentin—Oedema—Epirubicin—liver cancer	0.000488	0.000511	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—liver cancer	0.000486	0.000509	CcSEcCtD
Gabapentin—Infection—Epirubicin—liver cancer	0.000485	0.000508	CcSEcCtD
Gabapentin—Cough—Doxorubicin—liver cancer	0.000483	0.000506	CcSEcCtD
Gabapentin—Shock—Epirubicin—liver cancer	0.00048	0.000503	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—liver cancer	0.000479	0.000502	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—liver cancer	0.000479	0.000501	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—liver cancer	0.000478	0.000501	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—liver cancer	0.000478	0.0005	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—liver cancer	0.000476	0.000499	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—liver cancer	0.000474	0.000497	CcSEcCtD
Gabapentin—BCAT1—Metabolism—EPT1—liver cancer	0.000472	0.0104	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Epirubicin—liver cancer	0.000472	0.000494	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—liver cancer	0.000471	0.000493	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—liver cancer	0.000471	0.000493	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—liver cancer	0.000471	0.000493	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—liver cancer	0.00047	0.000492	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000468	0.00049	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—liver cancer	0.000465	0.000488	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—liver cancer	0.000465	0.000487	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—liver cancer	0.000461	0.000483	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR4—liver cancer	0.00046	0.0102	CbGpPWpGaD
Gabapentin—Hypotension—Epirubicin—liver cancer	0.000456	0.000478	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—liver cancer	0.000455	0.000477	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—liver cancer	0.000452	0.000473	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—liver cancer	0.000452	0.000473	CcSEcCtD
Gabapentin—Infection—Doxorubicin—liver cancer	0.000449	0.00047	CcSEcCtD
Gabapentin—BCAT1—Metabolism—TAT—liver cancer	0.000447	0.00988	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000445	0.000466	CcSEcCtD
Gabapentin—Shock—Doxorubicin—liver cancer	0.000444	0.000465	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—liver cancer	0.000443	0.000464	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—liver cancer	0.000443	0.00978	CbGpPWpGaD
Gabapentin—Thrombocytopenia—Doxorubicin—liver cancer	0.000442	0.000463	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—liver cancer	0.000441	0.000462	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—liver cancer	0.000441	0.000462	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—liver cancer	0.000439	0.00046	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—liver cancer	0.000438	0.000459	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—liver cancer	0.000437	0.000457	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—liver cancer	0.000435	0.000456	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—liver cancer	0.000434	0.000455	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—liver cancer	0.000431	0.000451	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—liver cancer	0.00043	0.00045	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.000427	0.00943	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—liver cancer	0.000425	0.00938	CbGpPWpGaD
Gabapentin—Decreased appetite—Epirubicin—liver cancer	0.000424	0.000444	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—liver cancer	0.000422	0.000442	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000421	0.000441	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—liver cancer	0.000421	0.000441	CcSEcCtD
Gabapentin—Pain—Epirubicin—liver cancer	0.000417	0.000437	CcSEcCtD
Gabapentin—Constipation—Epirubicin—liver cancer	0.000417	0.000437	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000411	0.000431	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—liver cancer	0.000408	0.000428	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—liver cancer	0.000406	0.000425	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—liver cancer	0.000403	0.000422	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—liver cancer	0.000402	0.000421	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—liver cancer	0.000402	0.000421	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BRAF—liver cancer	0.000401	0.00885	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Epirubicin—liver cancer	0.000399	0.000418	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—liver cancer	0.000398	0.000416	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—liver cancer	0.000393	0.000411	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00039	0.000408	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—liver cancer	0.000389	0.000408	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—liver cancer	0.000388	0.000406	CcSEcCtD
Gabapentin—Pain—Doxorubicin—liver cancer	0.000386	0.000405	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—liver cancer	0.000386	0.000405	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—liver cancer	0.000386	0.000404	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—liver cancer	0.000386	0.000404	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—liver cancer	0.000372	0.00039	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000369	0.000387	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.000366	0.00808	CbGpPWpGaD
Gabapentin—Hypersensitivity—Epirubicin—liver cancer	0.00036	0.000377	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—liver cancer	0.000359	0.000376	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—liver cancer	0.000357	0.000374	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—liver cancer	0.000357	0.000374	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—liver cancer	0.00035	0.000367	CcSEcCtD
Gabapentin—Pruritus—Epirubicin—liver cancer	0.000345	0.000362	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—RAF1—liver cancer	0.000335	0.00739	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—liver cancer	0.000334	0.00035	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—liver cancer	0.000333	0.000349	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—liver cancer	0.000324	0.000339	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—liver cancer	0.000323	0.000338	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—liver cancer	0.00032	0.000335	CcSEcCtD
Gabapentin—Vomiting—Epirubicin—liver cancer	0.00031	0.000325	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—liver cancer	0.000309	0.000324	CcSEcCtD
Gabapentin—Rash—Epirubicin—liver cancer	0.000308	0.000322	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—liver cancer	0.000307	0.000322	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—BRAF—liver cancer	0.000307	0.00678	CbGpPWpGaD
Gabapentin—Headache—Epirubicin—liver cancer	0.000306	0.00032	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—UGDH—liver cancer	0.000304	0.00672	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CPT1B—liver cancer	0.000304	0.00672	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GLUL—liver cancer	0.000304	0.00672	CbGpPWpGaD
Gabapentin—Dizziness—Doxorubicin—liver cancer	0.000299	0.000313	CcSEcCtD
Gabapentin—BCAT1—Metabolism—NR1H4—liver cancer	0.000293	0.00648	CbGpPWpGaD
Gabapentin—Nausea—Epirubicin—liver cancer	0.00029	0.000304	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GSTA3—liver cancer	0.000288	0.00637	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—liver cancer	0.000287	0.000301	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—EPT1—liver cancer	0.000286	0.00632	CbGpPWpGaD
Gabapentin—Rash—Doxorubicin—liver cancer	0.000285	0.000298	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—liver cancer	0.000285	0.000298	CcSEcCtD
Gabapentin—Headache—Doxorubicin—liver cancer	0.000283	0.000296	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CCR4—liver cancer	0.000279	0.00616	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TAT—liver cancer	0.000271	0.00599	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—liver cancer	0.000268	0.000281	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000265	0.00586	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA4—liver cancer	0.000264	0.00582	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA2—liver cancer	0.000257	0.00568	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—RAF1—liver cancer	0.000256	0.00566	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA1—liver cancer	0.000248	0.00548	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NAT2—liver cancer	0.000245	0.00541	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALDOB—liver cancer	0.000235	0.00519	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARA—liver cancer	0.000233	0.00515	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CRABP1—liver cancer	0.000224	0.00495	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000222	0.00489	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CHN2—liver cancer	0.000212	0.00469	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BRAF—liver cancer	0.000203	0.00449	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HPGDS—liver cancer	0.000196	0.00433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IFT88—liver cancer	0.000194	0.00429	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—liver cancer	0.000193	0.00425	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CPT1B—liver cancer	0.000184	0.00407	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GLUL—liver cancer	0.000184	0.00407	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—liver cancer	0.000184	0.00407	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NR1H4—liver cancer	0.000178	0.00392	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA3—liver cancer	0.000175	0.00386	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSMA4—liver cancer	0.000175	0.00386	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSMD10—liver cancer	0.000175	0.00386	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SERPINE1—liver cancer	0.000174	0.00383	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GOT2—liver cancer	0.00017	0.00375	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—RAF1—liver cancer	0.00017	0.00375	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—TRIO—liver cancer	0.000164	0.00363	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA4—liver cancer	0.00016	0.00353	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2E1—liver cancer	0.00016	0.00353	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR4—liver cancer	0.000158	0.00348	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA2—liver cancer	0.000156	0.00344	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA1—liver cancer	0.00015	0.00332	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYCS—liver cancer	0.000149	0.0033	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—TRIO—liver cancer	0.000149	0.00329	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAT2—liver cancer	0.000149	0.00328	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GOT1—liver cancer	0.000147	0.00324	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GGT1—liver cancer	0.000147	0.00324	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000146	0.00323	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR4—liver cancer	0.000143	0.00316	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALDOB—liver cancer	0.000142	0.00314	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—HRAS—liver cancer	0.000141	0.00312	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—JUN—liver cancer	0.000137	0.00302	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CRABP1—liver cancer	0.000136	0.003	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTP1—liver cancer	0.000132	0.00291	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMOX1—liver cancer	0.00013	0.00287	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—MAPK8—liver cancer	0.000129	0.00285	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000122	0.00269	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—liver cancer	0.000121	0.00267	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SHC3—liver cancer	0.000119	0.00263	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HPGDS—liver cancer	0.000119	0.00262	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A1—liver cancer	0.000115	0.00253	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—F2—liver cancer	0.000111	0.00246	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—liver cancer	0.000107	0.00236	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PSMA4—liver cancer	0.000106	0.00234	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PSMD10—liver cancer	0.000106	0.00234	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARA—liver cancer	0.000105	0.00232	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT2—liver cancer	0.000103	0.00227	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2E1—liver cancer	9.68e-05	0.00214	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—liver cancer	9.35e-05	0.00206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FST—liver cancer	9.24e-05	0.00204	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCE—liver cancer	9.07e-05	0.002	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYCS—liver cancer	9.06e-05	0.002	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—liver cancer	9.02e-05	0.00199	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—liver cancer	8.99e-05	0.00199	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT1—liver cancer	8.89e-05	0.00196	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GGT1—liver cancer	8.89e-05	0.00196	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TRIO—liver cancer	8.81e-05	0.00195	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—liver cancer	8.68e-05	0.00192	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR4—liver cancer	8.45e-05	0.00187	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—liver cancer	8.25e-05	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCE—liver cancer	8.24e-05	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CSF2—liver cancer	8.02e-05	0.00177	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—liver cancer	7.98e-05	0.00176	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—liver cancer	7.9e-05	0.00175	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—liver cancer	7.87e-05	0.00174	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—liver cancer	7.8e-05	0.00172	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—liver cancer	7.34e-05	0.00162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CSF2—liver cancer	7.29e-05	0.00161	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—liver cancer	6.95e-05	0.00154	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—liver cancer	6.89e-05	0.00152	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADAM17—liver cancer	6.68e-05	0.00148	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—liver cancer	6.48e-05	0.00143	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARA—liver cancer	6.36e-05	0.0014	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2—liver cancer	6.3e-05	0.00139	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSMA4—liver cancer	6.28e-05	0.00139	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSMD10—liver cancer	6.28e-05	0.00139	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—liver cancer	6.03e-05	0.00133	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2—liver cancer	5.72e-05	0.00126	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—liver cancer	5.47e-05	0.00121	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—liver cancer	5.45e-05	0.0012	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—liver cancer	5.3e-05	0.00117	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—liver cancer	5.26e-05	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCE—liver cancer	4.87e-05	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—liver cancer	4.81e-05	0.00106	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—liver cancer	4.79e-05	0.00106	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—liver cancer	4.73e-05	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—liver cancer	4.62e-05	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—liver cancer	4.61e-05	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CSF2—liver cancer	4.3e-05	0.000951	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAF1—liver cancer	4.29e-05	0.000948	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—H2AFX—liver cancer	4.24e-05	0.000937	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—liver cancer	4.24e-05	0.000936	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—liver cancer	4.2e-05	0.000927	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—liver cancer	4.19e-05	0.000926	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—liver cancer	4.17e-05	0.000922	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—liver cancer	3.85e-05	0.00085	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—liver cancer	3.84e-05	0.000847	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—liver cancer	3.51e-05	0.000775	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK14—liver cancer	3.49e-05	0.00077	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—liver cancer	3.43e-05	0.000758	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—liver cancer	3.42e-05	0.000755	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2—liver cancer	3.38e-05	0.000746	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APC—liver cancer	3.23e-05	0.000714	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—liver cancer	3.23e-05	0.000714	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—liver cancer	3.04e-05	0.000671	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—liver cancer	2.84e-05	0.000628	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—liver cancer	2.81e-05	0.000622	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—liver cancer	2.81e-05	0.000621	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—liver cancer	2.78e-05	0.000614	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—liver cancer	2.56e-05	0.000564	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—liver cancer	2.54e-05	0.000562	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAF1—liver cancer	2.54e-05	0.00056	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—liver cancer	2.48e-05	0.000547	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—liver cancer	2.48e-05	0.000547	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—liver cancer	2.36e-05	0.000522	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—liver cancer	2.32e-05	0.000513	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—liver cancer	2.3e-05	0.000508	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—liver cancer	2.28e-05	0.000503	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—liver cancer	2.27e-05	0.000502	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—liver cancer	2.26e-05	0.0005	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—liver cancer	2.22e-05	0.00049	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUN—liver cancer	2.21e-05	0.000489	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—liver cancer	2.2e-05	0.000485	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—liver cancer	2.15e-05	0.000475	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—liver cancer	2.15e-05	0.000474	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK8—liver cancer	2.09e-05	0.000462	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—liver cancer	2.09e-05	0.000461	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—liver cancer	2.08e-05	0.000459	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—liver cancer	1.93e-05	0.000427	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—liver cancer	1.91e-05	0.000423	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—liver cancer	1.78e-05	0.000393	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—liver cancer	1.77e-05	0.000392	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—liver cancer	1.64e-05	0.000363	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—liver cancer	1.51e-05	0.000333	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—liver cancer	1.46e-05	0.000323	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—liver cancer	1.4e-05	0.000308	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—liver cancer	1.34e-05	0.000295	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—liver cancer	1.23e-05	0.000272	CbGpPWpGaD
